AGAPE ATP CORPORATION Related Party Transaction, Purchases from Related Party
AGAPE ATP CORPORATION (ATPC) reported Related Party Transaction, Purchases from Related Party of $79.91 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes
us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty · last filed 2024-11-14
- AGAPE ATP CORPORATION related party transaction, purchases from related party for the quarter ending 2024-09-30 was $79.91K, a 8.79% increase year-over-year.
- AGAPE ATP CORPORATION related party transaction, purchases from related party for the quarter ending 2024-06-30 was $81.32K, a 45.67% increase year-over-year.
- AGAPE ATP CORPORATION related party transaction, purchases from related party for the quarter ending 2024-03-31 was $97.03K, a 156.10% increase year-over-year.
- AGAPE ATP CORPORATION related party transaction, purchases from related party for the quarter ending 2023-12-31 was $89.87K, a 29.26% increase year-over-year.
- AGAPE ATP CORPORATION related party transaction, purchases from related party for fiscal 2023 was $295.86K, a 46.12% increase from fiscal 2022.
- AGAPE ATP CORPORATION related party transaction, purchases from related party for fiscal 2022 was $202.47K, a 28099.86% increase from fiscal 2021.
- AGAPE ATP CORPORATION related party transaction, purchases from related party for fiscal 2021 was $718.00.
| Period end | Related Party Transaction, Purchases from Related Party 3 month | Related Party Transaction, Purchases from Related Party 6 month | Related Party Transaction, Purchases from Related Party 9 month | Related Party Transaction, Purchases from Related Party 12 month |
|---|---|---|---|---|
| 2024-09-30 | $79.91K 10-Q · filed 2024-11-14 | $161.23K derived: sum of 2 quarters · filed 2024-11-14 | $263.23K 10-Q · filed 2024-11-14 | $348.13K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | $81.32K 10-Q · filed 2024-08-14 | $178.43K 10-Q · filed 2024-08-14 | $268.22K derived: sum of 3 quarters · filed 2024-08-14 | $341.67K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-03-31 | $97.03K 10-Q · filed 2024-05-14 | $186.90K derived: sum of 2 quarters · filed 2024-05-14 | $260.35K derived: sum of 3 quarters · filed 2024-11-14 | $316.17K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-12-31 | $89.87K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $163.32K derived: sum of 2 quarters · filed 2024-11-14 | $219.15K derived: sum of 3 quarters · filed 2024-11-14 | $295.86K 10-K · filed 2024-04-01 |
| 2023-09-30 | $73.45K 10-Q · filed 2024-11-14 | $129.28K derived: sum of 2 quarters · filed 2024-11-14 | $205.99K 10-Q · filed 2024-11-14 | $236.69K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $55.83K 10-Q · filed 2024-08-14 | $134.03K 10-Q · filed 2024-08-14 | $163.24K derived: sum of 3 quarters · filed 2024-08-14 | $222.11K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $37.89K 10-Q · filed 2024-05-14 | $107.41K derived: sum of 2 quarters · filed 2024-05-14 | $166.29K derived: sum of 3 quarters · filed 2024-05-14 | $229.95K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $69.53K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $128.40K derived: sum of 2 quarters · filed 2024-04-01 | $192.07K derived: sum of 3 quarters · filed 2024-04-01 | $202.47K 10-K · filed 2024-04-01 |
| 2022-09-30 | $58.88K 10-Q · filed 2023-11-14 | $122.54K derived: sum of 2 quarters · filed 2023-11-14 | $132.95K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $63.66K 10-Q · filed 2023-08-14 | $75.43K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $12.01K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $718.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |